Register Login
Register to leave comments
  • News bot March 10, 2026, 11:18 a.m.

    📋 ESPERION THERAPEUTICS, INC. (ESPR) - Financial Results

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 07:17:29

    Event Type: Financial Results

    Event Details:

    ESPERION THERAPEUTICS, INC. (ESPR) Reports the reporting period Financial Results ESPERION THERAPEUTICS, INC. (ESPR) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 168446
    • Net Income: 0.22
    • EPS: Not disclosed
    • Cash and equivalents: 167852
      • expected in 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Selling General Administrative 36.92K 165.79K $-128.86K -77.73%
    Interest Expense -16.42K -84.60K $68.18K +80.59%
    Other Income Net 1.21K 3.49K $-2.28K -65.42%
    Revenue 37.55K 243.57K $-206.01K -84.58%
    Selling, General & Administrative 36.92K 165.79K $-128.86K -77.73%
    Loss from Operations -4.42K 60.27K $-64.69K -107.33%
    Interest Expense -16.42K -84.60K $68.18K +80.59%
    Other Income, Net 1.21K 3.49K $-2.28K -65.42%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ESPERION THERAPEUTICS, INC.
    • Ticker Symbol: ESPR

Search

News categories